// App-Quantinova.ai

OC01.04 : Aspirin versus placebo in pregnancies at high‐risk of preterm pre‐eclampsia: a multicentre, double‐blind, placebo‐controlled trial

Researchers

Presenter

  • D. Rolnik

Principal Investigators

  • L. Poon

  • N. O'Gorman

  • A. Syngelaki

  • C. de Paco Matallana

  • R. Akolekar

  • S. Cicero

  • D. Janga

  • M. Singh

  • F. Molina

  • N. Perisco

  • J. Jani

  • W. Plasencia

  • G. Papaioannou

  • K. Tennebaum Gavish

  • H. Meiri

  • S. Gizurarson

  • K.H. Nicolaides

Medical Centers

  • Kings College London, London, United Kingdom

  • University of Exeter, Exeter, United Kingdom

  • Obstetrics and Gynecology, Chinese University of Hong Kong, Hong Kong

  • Hospital Clinico Universitario Virgen de la Arrixaca, Murcia, Spain

  • Medway Maritime Hospital, Gillingham, United Kingdom

  • Neonatal Unit, Croydon University Hospital, London, United Kingdom

  • West Middlesex University Hospital, London, United Kingdom

  • Southend University Hospital, Essex, United Kingdom

  • Hospital Universitario San Cecilio, Granada, Spain

  • C Granda Foundation Ospedale Maggiore Policlinico, Milan, Italy

  • Centre Hospitalier Universitaire St Pierre, Brussels, Belgium

  • Hospital Universitario Materno Infantil de Canarias, Canary Islands, Spain

  • Attikon University Hospital, Athens, Greece.

  • Women's Hospital at Rabin Medical Centre, Tel Aviv, Israel

  • HyLabs Diagnostics, Tel Aviv, Israel

  • Hananja Ehf, University of Iceland, Reykjavik, Iceland

Locations

  • United Kingdom

  • Hong Kong

  • Spain

  • Italy

  • Belgium

  • Greece

  • Israel

  • Iceland

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • Placebo Control

  • Double Blind/Blinded

  • Multicenteric

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved